Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

The MYB-NFIB gene fusion-a novel genetic link between adenoid cystic carcinoma and dermal cylindroma.

Fehr A, Kovács A, Löning T, Frierson H Jr, van den Oord J, Stenman G.

J Pathol. 2011 Jul;224(3):322-7. doi: 10.1002/path.2909. Epub 2011 May 27.

PMID:
21618541
2.

Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms.

Brill LB 2nd, Kanner WA, Fehr A, Andrén Y, Moskaluk CA, Löning T, Stenman G, Frierson HF Jr.

Mod Pathol. 2011 Sep;24(9):1169-76. doi: 10.1038/modpathol.2011.86. Epub 2011 May 13.

3.

Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck.

Persson M, Andrén Y, Mark J, Horlings HM, Persson F, Stenman G.

Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18740-4. doi: 10.1073/pnas.0909114106. Epub 2009 Oct 19.

4.

Adenoid cystic carcinoma of the lacrimal gland: MYB gene activation, genomic imbalances, and clinical characteristics.

von Holstein SL, Fehr A, Persson M, Therkildsen MH, Prause JU, Heegaard S, Stenman G.

Ophthalmology. 2013 Oct;120(10):2130-8. doi: 10.1016/j.ophtha.2013.03.030. Epub 2013 May 29.

PMID:
23725736
5.

New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma.

Bhaijee F, Pepper DJ, Pitman KT, Bell D.

Ann Diagn Pathol. 2011 Feb;15(1):69-77. doi: 10.1016/j.anndiagpath.2010.12.001. Review.

PMID:
21238915
6.

Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome.

Mitani Y, Rao PH, Futreal PA, Roberts DB, Stephens PJ, Zhao YJ, Zhang L, Mitani M, Weber RS, Lippman SM, Caulin C, El-Naggar AK.

Clin Cancer Res. 2011 Nov 15;17(22):7003-14. doi: 10.1158/1078-0432.CCR-11-1870. Epub 2011 Oct 5.

7.

Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance.

Mitani Y, Li J, Rao PH, Zhao YJ, Bell D, Lippman SM, Weber RS, Caulin C, El-Naggar AK.

Clin Cancer Res. 2010 Oct 1;16(19):4722-31. doi: 10.1158/1078-0432.CCR-10-0463. Epub 2010 Aug 11.

8.

Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma.

Persson M, Andrén Y, Moskaluk CA, Frierson HF Jr, Cooke SL, Futreal PA, Kling T, Nelander S, Nordkvist A, Persson F, Stenman G.

Genes Chromosomes Cancer. 2012 Aug;51(8):805-17. doi: 10.1002/gcc.21965. Epub 2012 Apr 16.

PMID:
22505352
9.

Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.

Mitani Y, Liu B, Rao PH, Borra VJ, Zafereo M, Weber RS, Kies M, Lozano G, Futreal PA, Caulin C, El-Naggar AK.

Clin Cancer Res. 2016 Feb 1;22(3):725-33. doi: 10.1158/1078-0432.CCR-15-2867-T. Epub 2015 Dec 2.

10.

MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features.

D'Alfonso TM, Mosquera JM, MacDonald TY, Padilla J, Liu YF, Rubin MA, Shin SJ.

Hum Pathol. 2014 Nov;45(11):2270-80. doi: 10.1016/j.humpath.2014.07.013. Epub 2014 Aug 7.

PMID:
25217885
11.

MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma.

Rettig EM, Tan M, Ling S, Yonescu R, Bishop JA, Fakhry C, Ha PK.

Laryngoscope. 2015 Sep;125(9):E292-9. doi: 10.1002/lary.25356. Epub 2015 May 11.

12.

Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.

Wetterskog D, Lopez-Garcia MA, Lambros MB, A'Hern R, Geyer FC, Milanezi F, Cabral MC, Natrajan R, Gauthier A, Shiu KK, Orr N, Shousha S, Gatalica Z, Mackay A, Palacios J, Reis-Filho JS, Weigelt B.

J Pathol. 2012 Jan;226(1):84-96. doi: 10.1002/path.2974. Epub 2011 Oct 20.

PMID:
22015727
13.

Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma.

Bell D, Roberts D, Karpowicz M, Hanna EY, Weber RS, El-Naggar AK.

Cancer Biol Ther. 2011 Oct 1;12(7):569-73. Epub 2011 Oct 1.

14.

Overexpression of MYB drives proliferation of CYLD-defective cylindroma cells.

Rajan N, Andersson MK, Sinclair N, Fehr A, Hodgson K, Lord CJ, Kazakov DV, Vanecek T, Ashworth A, Stenman G.

J Pathol. 2016 Jun;239(2):197-205. doi: 10.1002/path.4717. Epub 2016 Apr 21.

15.

Detection of MYB Alterations and Other Immunohistochemical Markers in Primary Cutaneous Adenoid Cystic Carcinoma.

North JP, McCalmont TH, Fehr A, van Zante A, Stenman G, LeBoit PE.

Am J Surg Pathol. 2015 Oct;39(10):1347-56. doi: 10.1097/PAS.0000000000000463.

PMID:
26076064
16.

A subset of prostatic basal cell carcinomas harbor the MYB rearrangement of adenoid cystic carcinoma.

Bishop JA, Yonescu R, Epstein JI, Westra WH.

Hum Pathol. 2015 Aug;46(8):1204-8. doi: 10.1016/j.humpath.2015.05.002. Epub 2015 May 22.

PMID:
26089205
17.

Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.

Brayer KJ, Frerich CA, Kang H, Ness SA.

Cancer Discov. 2016 Feb;6(2):176-87. doi: 10.1158/2159-8290.CD-15-0859. Epub 2015 Dec 2.

18.

MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation.

West RB, Kong C, Clarke N, Gilks T, Lipsick JS, Cao H, Kwok S, Montgomery KD, Varma S, Le QT.

Am J Surg Pathol. 2011 Jan;35(1):92-9. doi: 10.1097/PAS.0b013e3182002777.

19.

Genomic landscape of adenoid cystic carcinoma of the breast.

Martelotto LG, De Filippo MR, Ng CK, Natrajan R, Fuhrmann L, Cyrta J, Piscuoglio S, Wen HC, Lim RS, Shen R, Schultheis AM, Wen YH, Edelweiss M, Mariani O, Stenman G, Chan TA, Colombo PE, Norton L, Vincent-Salomon A, Reis-Filho JS, Weigelt B.

J Pathol. 2015 Oct;237(2):179-89. doi: 10.1002/path.4573. Epub 2015 Jul 14.

20.

Development and characterization of xenograft model systems for adenoid cystic carcinoma.

Moskaluk CA, Baras AS, Mancuso SA, Fan H, Davidson RJ, Dirks DC, Golden WL, Frierson HF Jr.

Lab Invest. 2011 Oct;91(10):1480-90. doi: 10.1038/labinvest.2011.105. Epub 2011 Jun 27.

Supplemental Content

Support Center